Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant YFV Envelope protein/E Protein, C-His

Catalog #:   EVV45101 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: Mammalian cells
Accession: Q89293
Protein length: Ala1-Ser395
Overview

Catalog No.

EVV45101

Expression system

Mammalian cells

Species

Yellow fever virus (YFV)

Protein length

Ala1-Ser395

Predicted molecular weight

43.98 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q89293

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Envelope protein, E

Data Image
References

Modes of action of a small molecule antiviral compound targeting yellow fever virus NS4B protein., PMID:40378003

A bivalent self-amplifying RNA vaccine against yellow fever and Zika viruses., PMID:40364846

Mechanism of Inhibition of the Active Triphosphate Form of 2'-α-Fluoro,2'-β-bromouridine against Yellow Fever Virus RNA-Dependent RNA Polymerase., PMID:40323779

Yellow fever virus infection alters mitochondrial network dynamics and trigger IFN-I response via TLR2 pathway., PMID:40300356

Bothropstoxins I and II as potent phospholipase A2 molecules from Bothrops jararacussu to impair hepatitis C virus infection., PMID:40288437

Immunoenzyme Test for Capture of IgM Anti-YFV Class Antibodies: MAC-ELISA., PMID:40249441

Micro-Focus Reduction Neutralization Tests (mFRNT) for Neutralizing Antibody (Nab) Quantification Against Yellow Fever Virus., PMID:40249436

Purification of Yellow Fever Virus by Liquid Chromatography., PMID:40249428

Type I Interferon-Induced Modification of Yellow Fever Virus NS5 Enhances Binding to Human STAT2., PMID:40249426

Immunofluorescence Assay., PMID:40249425

Immunoenzyme Test for Detection of IgG Anti-YFV Class Antibodies: IgG-ELISA., PMID:40249424

Seropositivity to Dengue, Zika, Yellow Fever, and West Nile Viruses in Senegal, West Africa., PMID:40207881

Histopathological Changes and Immune Response Profile in the Brains of Non-Human Primates Naturally Infected with Yellow Fever Virus., PMID:40143314

Antigen-specific T cell responses following single and co-administration of tick-borne encephalitis, Japanese encephalitis, and yellow fever virus vaccines: Results from an open-label, non-randomized clinical trial-cohort., PMID:40019865

A single residue in domain II of envelope protein of yellow fever virus is critical for neutralization sensitivity., PMID:40019254

Antiviral metabolites from Passiflora edulis: An in vitro, phytochemical, and computational studies., PMID:39945526

Characterisation of clinical response and transcriptional profiling of proliferating CD8 T cells in the blood of cancer patients after PD-1 monotherapy or combination therapy., PMID:39886145

Dengue virus is particularly sensitive to interference with long-chain fatty acid elongation and desaturation., PMID:39863099

Development of nucleic acid-based vaccines against dengue and other mosquito-borne flaviviruses: the past, present, and future., PMID:39840044

Dengue and Zika virus NS4B proteins differ in topology and in determinants of ER membrane protein complex dependency., PMID:39745435

Undetected circulation of major arboviruses in West Sudan: urging for institutionalizing multisectoral one health strategy for the preparedness, prevention, and control of zoonotic arboviral diseases., PMID:39726037

Detection of neutralizing antibodies against arboviruses from liver homogenates., PMID:39671423

Wild Brazilian yellow fever virus infection in Syrian hamsters (Mesocricetus auratus): Clinical and histopathological analyses., PMID:39622385

Yellow fever disease severity and endothelial dysfunction are associated with elevated serum levels of viral NS1 protein and syndecan-1., PMID:39454515

2'-O-methyltransferase-deficient yellow fever virus: Restricted replication in the midgut and secondary tissues of Aedes aegypti mosquitoes severely limits dissemination., PMID:39356716

High-throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development., PMID:39291820

Insect cell production of chimeric virus-like particles based on human immunodeficiency virus GAG proteins and yellow fever virus envelope protein., PMID:39254800

Novel Pyrazino[1,2-a]indole-1,3(2H,4H)-dione Derivatives Targeting the Replication of Flaviviridae Viruses: Structural and Mechanistic Insights., PMID:39205212

Structural Insights into the Dynamic Assembly of a YFV sNS1 Tetramer., PMID:39205186

The Flavivirus Non-Structural Protein 5 (NS5): Structure, Functions, and Targeting for Development of Vaccines and Therapeutics., PMID:39203991

No Yellow Fever Vaccine Reactions in IgE-Mediated Egg Allergic Patients., PMID:39137738

Comparative Evaluation of Select Serological Assays for Zika Virus Using Blinded Reference Panels., PMID:39066237

Serological Evidence of Zika Virus Infections in Sudan., PMID:39066208

Development of a hydrogen peroxide-inactivated vaccine that protects against viscerotropic yellow fever in a non-human primate model., PMID:39019010

Mechanisms of Flavivirus Cross-Protection against Yellow Fever in a Mouse Model., PMID:38932129

Baculovirus surface display of a chimeric E-NS1 protein of YFV protects against YFV infection., PMID:38852036

Human antibodies in Mexico and Brazil neutralizing tick-borne flaviviruses., PMID:38819991

Comparison of Five Serological Methods for the Detection of West Nile Virus Antibodies., PMID:38793670

[Preparation of monoclonal antibodies against the envelope protein extracellular domain of Zika virus in mice]., PMID:38790101

Advancing molecular modeling and reverse vaccinology in broad-spectrum yellow fever virus vaccine development., PMID:38735993

Residue K28 of Zika Virus NS5 Protein Is Implicated in Virus Replication and Antagonism of STAT2., PMID:38674605

Differentiation marker-negative CD4+ T cells persist after yellow fever virus vaccination and contribute to durable memory., PMID:38559113

Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017-2018 sylvatic outbreak in Brazil., PMID:38511952

The Role of Noncoding RNA in the Transmission and Pathogenicity of Flaviviruses., PMID:38400018

Development of a quantitative NS1 antigen enzyme-linked immunosorbent assay (ELISA) for Zika virus detection using a novel virus-specific mAb., PMID:38291109

Yellow fever virus infection in human hepatocyte cells triggers an imbalance in redox homeostasis with increased reactive oxygen species production, oxidative stress, and decreased antioxidant enzymes., PMID:38278309

Generation of Viral Particles with Brain Cell-Specific Tropism by Pseudotyping HIV-1 with the Zika Virus E Protein., PMID:38251196

Detection of anti-premembrane antibody as a specific marker of four flavivirus serocomplexes and its application to serosurveillance in endemic regions., PMID:38163752

Elongation of N6-benzyladenosine scaffold via Pd-catalyzed C-C bond formation leads to derivatives with antiflaviviral activity., PMID:38128296

Yellow fever vaccine-associated neurologic and viscerotropic disease: a 10-year case series of the French National Reference Center for Arboviruses with clinical and immunological insights., PMID:38123499

Datasheet
$ 480
Product specifications
100 μg 480 1 mg 2880

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant YFV Envelope protein/E Protein, C-His [EVV45101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only